510(k) for Medtox Scientific:
This article was originally published in Clinica
The Profile-II system developed by Medtox Scientific has been approved by the FDA. The system is an on-site drugs-of-abuse test kit which is able to detect the five most common drugs of abuse - cannabanoids, cocaine, opiates, amphetamines and PCP - in one step using a single sample. The company expects to begin shipping the product next month.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.